Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139737
Status:
COMPLETED
Last Update Posted:
2021-03-03
First Post:
2005-08-29
Brief Title:
Extension Study Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Schizophrenia |
Keywords:
| Name | View |
|---|---|
| Open-label extension Ziprasidone study in Schizophrenia | View |